Glaucoma is characterized by damage to the optic nerve, a vital part of the eye responsible for transmitting visual information to the brain. This damage is most frequently linked to an elevation in the pressure within the eye, known as intraocular pressure. Understanding this connection is key to recognizing the condition. In its early stages, glaucoma typically presents no noticeable symptoms, making early detection crucial.

The Silent Threat: No Early Symptoms

A significant challenge with glaucoma is its silent progression. In the initial stages, individuals often do not experience any symptoms. This absence of early warning signs underscores why screening is essential to detect glaucoma before it advances and causes irreversible damage.

Who Needs Glaucoma Screening?

To identify glaucoma in its early stages, screening is highly recommended. Individuals above the age of 40, particularly those with a family history of glaucoma, should consider consulting an ophthalmologist. This consultation allows for a thorough screening of the optic nerve.

Your Ophthalmologist’s Role in Screening

During your visit, the ophthalmologist will examine your optic nerve. Based on this assessment, the doctor will determine if any further specific glaucoma screening tests are necessary. This personalized approach helps ensure appropriate diagnostic steps are taken for your eye health.

Why Early Detection is Crucial

It is important to note that once glaucoma reaches a very late stage, it can become significantly more challenging to treat effectively. Therefore, prioritizing early screening is a vital step in managing this condition and preserving your vision and overall eye health.

Dr. KM Cherian Institute of Medical Sciences is a pioneer in delivering world-renowned treatment procedures at affordable costs. We continually upgrade the quality of the healthcare ecosystem and enable faster recovery for patients from all backgrounds.